Alembic Pharmaceuticals' (NSE:APLLTD, BOM:533573) consolidated profit rose to 1.54 billion Indian rupees in the fiscal first quarter ended June 30, against 1.35 billion rupees a year ago.
Earnings per share came in at 7.85 rupees compared with the 6.84 rupees a year earlier, the pharmaceuticals manufacturer said in a Tuesday filing to the Indian stock exchanges.
Revenue from operations in fiscal Q1 also increased to 17.1 billion rupees from 15.6 billion rupees a year ago.
The company's shares were down over 1% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.